Business Context and Reporting Period
Company: AngioDynamics, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: March 29, 2018
Context: This filing serves as a Regulation FD disclosure to furnish presentation slides regarding the company's fiscal third quarter ended February 28, 2018.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the attached presentation slides (Exhibit 99.1) but are not detailed in the body of this Form 8-K.
Material Changes
No material changes to financial performance or operations are described in the text of this filing. The document solely references the availability of presentation materials for the fiscal third quarter.
Guidance, Outlook, and Risks
Management Commentary: The filing references presentation slides discussing the fiscal third quarter results.
Legal Status of Information: The information in the attached slides is furnished pursuant to Item 7.01 and is explicitly not deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934. Consequently, the information is not subject to the liabilities under that Section and shall not be incorporated by reference into other filings under the Securities Act of 1933.
Risks and Contingencies: No specific risks or contingencies are detailed in this filing text.
Investor Verification Checklist
- Review Exhibit 99.1 (Presentation dated March 29, 2018) for actual financial figures and management commentary.
- Confirm that the presentation slides are not considered "filed" documents for liability purposes under Section 18 of the Exchange Act.
- Verify the fiscal quarter end date referenced in the slides is February 28, 2018.